Centro de Imagem Diagnósticos S.A (AALR3) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.334x

Based on the latest financial reports, Centro de Imagem Diagnósticos S.A (AALR3) has a cash flow conversion efficiency ratio of 0.334x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (R$-84.32 Million ≈ $-16.54 Million USD) by net assets (R$-252.23 Million ≈ $-49.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Centro de Imagem Diagnósticos S.A for the company's overall valuation and market capitalisation.

Centro de Imagem Diagnósticos S.A - Cash Flow Conversion Efficiency Trend (2010–2025)

This chart illustrates how Centro de Imagem Diagnósticos S.A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Centro de Imagem Diagnósticos S.A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Centro de Imagem Diagnósticos S.A ranked by their cash flow conversion efficiency. Explore cash flow quality index of Centro de Imagem Diagnósticos S.A to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Hurriyet Gazetecilik ve Matbaacilik AS
IS:HURGZ
-0.435x
Serrano 61 Desarrollo SOCIMI SA
MC:YSRR
-0.002x
Sree Rayalaseema Hi-Strength Hypo Limited
NSE:SRHHYPOLTD
0.019x
Scientex Packaging
KLSE:8125
0.042x
Chateau International Development Co Ltd
TW:2722
-0.003x
Nasmedia Co. Ltd
KQ:089600
-0.051x
Kaiser Reef Ltd
AU:KAU
0.405x
Ritco Logistics Limited
NSE:RITCO
0.019x

Annual Cash Flow Conversion Efficiency for Centro de Imagem Diagnósticos S.A (2010–2025)

The table below shows the annual cash flow conversion efficiency of Centro de Imagem Diagnósticos S.A from 2010 to 2025. View AALR3 stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 R$-252.23 Million
≈ $-49.49 Million
R$102.22 Million
≈ $20.06 Million
-0.405x -1023.05%
2024-12-31 R$1.14 Billion
≈ $223.06 Million
R$-41.02 Million
≈ $-8.05 Million
-0.036x -133.30%
2023-12-31 R$943.99 Million
≈ $185.23 Million
R$102.30 Million
≈ $20.07 Million
0.108x -43.19%
2022-12-31 R$981.92 Million
≈ $192.67 Million
R$187.30 Million
≈ $36.75 Million
0.191x +54.70%
2021-12-31 R$1.21 Billion
≈ $237.31 Million
R$149.13 Million
≈ $29.26 Million
0.123x +28.02%
2020-12-31 R$1.22 Billion
≈ $240.11 Million
R$117.86 Million
≈ $23.13 Million
0.096x -40.42%
2019-12-31 R$1.32 Billion
≈ $259.01 Million
R$213.41 Million
≈ $41.87 Million
0.162x +30.36%
2018-12-31 R$1.30 Billion
≈ $255.03 Million
R$161.19 Million
≈ $31.63 Million
0.124x +17.39%
2017-12-31 R$1.27 Billion
≈ $249.25 Million
R$134.19 Million
≈ $26.33 Million
0.106x +62.12%
2016-12-31 R$1.21 Billion
≈ $237.80 Million
R$78.97 Million
≈ $15.50 Million
0.065x -51.54%
2015-12-31 R$733.00 Million
≈ $143.83 Million
R$98.56 Million
≈ $19.34 Million
0.134x +109.55%
2014-12-31 R$743.32 Million
≈ $145.85 Million
R$47.69 Million
≈ $9.36 Million
0.064x +4.79%
2013-12-31 R$279.49 Million
≈ $54.84 Million
R$17.11 Million
≈ $3.36 Million
0.061x -63.19%
2012-12-31 R$234.93 Million
≈ $46.10 Million
R$39.07 Million
≈ $7.67 Million
0.166x +29.64%
2011-12-31 R$257.14 Million
≈ $50.46 Million
R$32.99 Million
≈ $6.47 Million
0.128x -58.17%
2010-12-31 R$35.66 Million
≈ $7.00 Million
R$10.94 Million
≈ $2.15 Million
0.307x --

About Centro de Imagem Diagnósticos S.A

SA:AALR3 Brazil Diagnostics & Research
Market Cap
$98.63 Million
R$502.66 Million BRL
Market Cap Rank
#19365 Global
#182 in Brazil
Share Price
R$3.30
Change (1 day)
+0.61%
52-Week Range
R$2.56 - R$6.76
All Time High
R$24.30
About

Alliança Saúde e Participações S.A. provides diagnostic imaging and medicine services in Brazil. The company offers diagnostic imaging, clinical analysis, nuclear medicine, genetic testing, and vaccination services, as well as corporate, remote, and in-person solutions for hospitals and diagnostic centers in the private and public sectors. It provides clinical analysis services, such as blood cou… Read more